SEC Filings for Anika Therapeutics Inc. (ANIK)

$ 42.00   -0.57 (-1.34%) Volume: 250.75k 4:00 PM EST Feb 20, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)2905/10/2018
8-KCurrent report pursuant to Section 13 or 15(d)905/02/2018
DEFA14AAdditional proxy soliciting materials - definitive504/17/2018
DEF 14AOther definitive proxy statements7704/17/2018
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals403/22/2018
4Statement of changes in beneficial ownership of securities103/13/2018
8-KCurrent report pursuant to Section 13 or 15(d)2203/08/2018
4Statement of changes in beneficial ownership of securities103/02/2018
4Statement of changes in beneficial ownership of securities103/02/2018
4Statement of changes in beneficial ownership of securities103/02/2018
4Statement of changes in beneficial ownership of securities103/02/2018
10-KAnnual report pursuant to Section 13 or 15(d)8502/27/2018
8-KCurrent report pursuant to Section 13 or 15(d)1102/21/2018
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/13/2018
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2018
123456789101112131415